Kinase inhibitors

Number of patents in Portfolio can not be more than 2000

United States of America Patent

PATENT NO 8907094
SERIAL NO

13708324

Stats

ATTORNEY / AGENT: (SPONSORED)

Importance

Loading Importance Indicators... loading....

Abstract

See full text

Compounds of formula (I) and pharmaceutically acceptable salts thereof:

Loading the Abstract Image... loading....

First Claim

See full text

Family

Loading Family data... loading....

Patent Owner(s)

Patent OwnerAddress
CHIESI FARMACEUTICI S P AITALY MILAN MILAN

International Classification(s)

Inventor(s)

Inventor Name Address # of filed Patents Total Citations
Alcaraz, Lilian Harlow, GB 36 219
Armani, Elisabetta Parma, IT 69 430
Cridland, Andrew Peter Harlow, GB 18 80
Hurley, Christopher Harlow, GB 31 246
Jennings, Andrew Stephen Robert Harlow, GB 16 93
Panchal, Terry Aaron Harlow, GB 14 93
Ray, Nicholas Charles Harlow, GB 60 328
Van, Niel Monique Bodil Harlow, GB 34 271

Cited Art Landscape

Load Citation

Patent Citation Ranking

Forward Cite Landscape

Load Citation

Maintenance Fees

Fee Large entity fee small entity fee micro entity fee due date
11.5 Year Payment $7400.00 $3700.00 $1850.00 Jun 9, 2026
Fee Large entity fee small entity fee micro entity fee
Surcharge - 11.5 year - Late payment within 6 months $160.00 $80.00 $40.00
Surcharge after expiration - Late payment is unavoidable $700.00 $350.00 $175.00
Surcharge after expiration - Late payment is unintentional $1,640.00 $820.00 $410.00